OpenVSafe by OpenVAERS
Search V-safe

ZC7-20195-35234

2 vaccinations 4 coded responses 13 check-ins 4 free-text entries 0 call cases
Sex
Female
Age at first dose
12-15
ZIP prefix
958 / CA
Registered
2021-10-01
Relationship
Child or adolescent in my care
Guardian
RKC-69455-83110
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-09-10
    Dose 1 — Pfizer-BioNTech
  2. 2021-10-01
    Registered in v-safe
  3. 2021-10-01
    Dose 2 — Pfizer-BioNTech
  4. 2021-10-01
    Health check-in — day 0, dose 2, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-10-03
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  6. 2021-10-04
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  7. 2021-10-05
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  8. 2021-10-06
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  9. 2021-10-07
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  10. 2021-10-08
    Health check-in — day 7, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  11. 2021-10-15
    Survey response — day 14, dose 2, dependent
    MedDRA: Headache — Feeling: Good · Be unable to do your normal daily activities
    Free text: Headache
    MedDRA releases: 2024-11 · check-in free text available
  12. 2021-10-24
    Survey response — day 21, dose 2, dependent
    MedDRA: Fatigue, Menstruation irregular, Migraine — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Migraine, fatigue, and delayed menstrual cycle
    MedDRA releases: 2024-11 · check-in free text available
  13. 2021-11-01
    Survey response — day 28, dose 2, dependent
    MedDRA: Menstruation delayed — Feeling: Good
    Free text: Delay in menstrual cycle.
    MedDRA releases: 2024-11 · check-in free text available
  14. 2021-11-10
    Health check-in — day 35, dose 2, dependent
    Feeling: Good
    Adult check-in
  15. 2021-12-31
    Survey response — 3 months, dose 2, dependent
    MedDRA: Dysmenorrhoea — Feeling: Good · Be unable to do your normal daily activities
    Free text: More painful menstrual pains.
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-04-01

Vaccinations

DoseDateManufacturerCo-administered
12021-09-10Pfizer-BioNTech No
22021-10-01Pfizer-BioNTech No

Free text

Release 10 — day 14, dose 2, dependent

2021-10-15

Symptoms: Headache

Release 10 — day 21, dose 2, dependent

2021-10-24

Symptoms: Migraine, fatigue, and delayed menstrual cycle

Release 10 — day 28, dose 2, dependent

2021-11-01

Symptoms: Delay in menstrual cycle.

Release 10 — 3 months, dose 2, dependent

2021-12-31

Symptoms: More painful menstrual pains.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDDysmenorrhoea · · ✓
SDFatigue · · ✓
SDHeadache · · ✓
SDMenstruation delayed · · ✓
SDMenstruation irregular · · ✓
SDMigraine · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release